JY231(Internal Clinical Drug Code) Injection for the Treatment of Refractory Autoimmune Diseases
JY231(Internal Clinical Drug Code) Injection for the Treatment of Refractory Autoimmune Diseases
Not yet recruiting · NCT06243159 · Registry updated 2024-02-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| JY231(Internal Clinical Drug Code) Injection for the Treatment of Refractory Autoimmune Diseases | autoimmune disease, immune system disorder | Not yet recruiting | Early phase 1 | 2024-02-06 | NCT06243159 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanxi Bethune Hospital | 33 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanxi Bethune Hospital | Taiyuan | China | 23 |